1. Home
  2. CEVA vs ABCL Comparison

CEVA vs ABCL Comparison

Compare CEVA & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CEVA
  • ABCL
  • Stock Information
  • Founded
  • CEVA 1999
  • ABCL 2012
  • Country
  • CEVA United States
  • ABCL Canada
  • Employees
  • CEVA N/A
  • ABCL N/A
  • Industry
  • CEVA Semiconductors
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • CEVA Technology
  • ABCL Health Care
  • Exchange
  • CEVA Nasdaq
  • ABCL Nasdaq
  • Market Cap
  • CEVA 666.8M
  • ABCL 719.0M
  • IPO Year
  • CEVA 2000
  • ABCL 2020
  • Fundamental
  • Price
  • CEVA $28.67
  • ABCL $2.72
  • Analyst Decision
  • CEVA Strong Buy
  • ABCL Buy
  • Analyst Count
  • CEVA 3
  • ABCL 3
  • Target Price
  • CEVA $33.67
  • ABCL $8.50
  • AVG Volume (30 Days)
  • CEVA 149.4K
  • ABCL 2.5M
  • Earning Date
  • CEVA 11-07-2024
  • ABCL 11-04-2024
  • Dividend Yield
  • CEVA N/A
  • ABCL N/A
  • EPS Growth
  • CEVA N/A
  • ABCL N/A
  • EPS
  • CEVA N/A
  • ABCL N/A
  • Revenue
  • CEVA $101,878,000.00
  • ABCL $32,962,000.00
  • Revenue This Year
  • CEVA $9.76
  • ABCL N/A
  • Revenue Next Year
  • CEVA $10.37
  • ABCL $38.78
  • P/E Ratio
  • CEVA N/A
  • ABCL N/A
  • Revenue Growth
  • CEVA N/A
  • ABCL N/A
  • 52 Week Low
  • CEVA $16.02
  • ABCL $2.34
  • 52 Week High
  • CEVA $30.00
  • ABCL $6.06
  • Technical
  • Relative Strength Index (RSI)
  • CEVA 65.72
  • ABCL 49.01
  • Support Level
  • CEVA $26.40
  • ABCL $2.57
  • Resistance Level
  • CEVA $28.39
  • ABCL $3.18
  • Average True Range (ATR)
  • CEVA 1.18
  • ABCL 0.19
  • MACD
  • CEVA 0.16
  • ABCL -0.02
  • Stochastic Oscillator
  • CEVA 80.27
  • ABCL 32.35

About CEVA CEVA Inc.

CEVA Inc is a licensor of signal-processing intellectual property. Through partnerships with semiconductor companies and original equipment manufacturers globally, the company helps produce devices for a range of end markets. OEMs and semiconductor companies choose to sell products with CEVA equipment to wireless, consumer, automotive, and Internet of Things companies. Revenue is derived primarily from licensing fees and related revenue, and royalties generated from the shipments of products utilizing its intellectual properties. CEVA also engages in the training and sale of development systems.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: